82 related articles for article (PubMed ID: 23301436)
1. How end-stage renal disease patients manage the Medicare Part D coverage gap.
Kovacs PJ; Perkins N; Nuschke E; Carroll N
Health Soc Work; 2012 Nov; 37(4):225-33. PubMed ID: 23301436
[TBL] [Abstract][Full Text] [Related]
2. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080
[TBL] [Abstract][Full Text] [Related]
3. Medicare Part D: challenges for dialysis patients. Part 1.
Smith S; Witten B; Paykin C; Weiner S; Chianchiano D; St Peter WL
Nephrol News Issues; 2011 Nov; 25(12):38-40, 42, 44-5. PubMed ID: 22204167
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease and medicare.
St Peter WL
J Manag Care Pharm; 2007 Dec; 13(9 Suppl D):S13-8. PubMed ID: 18177214
[TBL] [Abstract][Full Text] [Related]
5. Cost-related nonadherence to prescribed medication therapy among Medicare Part D beneficiaries with end-stage renal disease.
Frankenfield DL; Howell BL; Wei II; Anderson KK
Am J Health Syst Pharm; 2011 Jul; 68(14):1339-48. PubMed ID: 21719594
[TBL] [Abstract][Full Text] [Related]
6. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
Patel UD; Davis MM
J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
[TBL] [Abstract][Full Text] [Related]
7. Potential impact of Medicare Part D in the end-stage renal disease population.
St Peter WL
Adv Chronic Kidney Dis; 2008 Apr; 15(2):140-6. PubMed ID: 18334238
[TBL] [Abstract][Full Text] [Related]
8. Lessons for Medicare Part D in the hemodialysis community.
Nayeem AI; Chertow GM
BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
[TBL] [Abstract][Full Text] [Related]
9. Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program Bid Surety Bonds, State Licensure and Appeals Process for Breach of Contract Actions, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program and Fee Schedule Adjustments, Access to Care Issues for Durable Medical Equipment; and the Comprehensive End-Stage Renal Disease Care Model. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2016 Nov; 81(214):77834-969. PubMed ID: 27905888
[TBL] [Abstract][Full Text] [Related]
10. Digesting the doughnut hole.
Joyce GF; Zissimopoulos J; Goldman DP
J Health Econ; 2013 Dec; 32(6):1345-55. PubMed ID: 24308883
[TBL] [Abstract][Full Text] [Related]
11. Increasing Medicare part D enrollment in medication therapy management could improve health and lower costs.
Stuart B; Loh FE; Roberto P; Miller LM
Health Aff (Millwood); 2013 Jul; 32(7):1212-20. PubMed ID: 23836736
[TBL] [Abstract][Full Text] [Related]
12. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.
Yala SM; Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF
BMC Health Serv Res; 2014 Dec; 14():665. PubMed ID: 25526892
[TBL] [Abstract][Full Text] [Related]
13. Anticipatory Behavior in Response to Medicare Part D's Coverage Gap.
Kaplan CM; Zhang Y
Health Econ; 2017 Mar; 26(3):338-351. PubMed ID: 26749399
[TBL] [Abstract][Full Text] [Related]
14. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
15. Association of Part D coverage gap with COPD medication adherence.
Yu YF; Hearld LR; Qu H; Ray MN; Kilgore ML
Am J Manag Care; 2016 Aug; 22(8):e275-82. PubMed ID: 27556829
[TBL] [Abstract][Full Text] [Related]
16. Medicare Program; Conditions for Coverage for End-Stage Renal Disease Facilities--Third Party Payment. Interim final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2016 Dec; 81(240):90211-28. PubMed ID: 28001019
[TBL] [Abstract][Full Text] [Related]
17. The Medicare Part D coverage gap: implications for non-dually eligible older adults with a mental illness.
Bakk L; Woodward AT; Dunkle RE
J Gerontol Soc Work; 2014; 57(1):37-51. PubMed ID: 24377835
[TBL] [Abstract][Full Text] [Related]
18. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
[TBL] [Abstract][Full Text] [Related]
19. Part D coverage gap and adherence to diabetes medications.
Gu Q; Zeng F; Patel BV; Tripoli LC
Am J Manag Care; 2010; 16(12):911-8. PubMed ID: 21348561
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the ESRD managed care demonstration operations.
Oppenheimer CC; Shapiro JR; Beronja N; Dykstra DM; Gaylin DS; Held PJ; Rubin RJ
Health Care Financ Rev; 2003; 24(4):7-29. PubMed ID: 14628397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
